Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (NY:RY)

147.41 +0.91 (+0.62%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
32 33 Next >
Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today
Via Benzinga
RBC BEARINGS INC (NYSE:RBC) – A Quality Stock with Strong Fundamentals
RBC Bearings (NYSE:RBC) is a quality stock with strong ROIC, EBIT growth, and profit quality, though its valuation remains high. Ideal for long-term investors. 
Via Chartmill
Salesforce Restarts Informatica Acquisition Talks, Say Reports. Deal Could Boost AI Push.
An Informatica deal could come at a lower prices, but still pressure Salesforce stock. 
Via Investor's Business Daily
Topics Artificial Intelligence
Illya Bailey Channels Institutional Power Through THEBAILEYOFFI Investment Consortium: CANADA-US TARIFFS AND THE RISE OF STRATEGIC CAPITAL
Reshaping Cross-Border Finance and Resource Dominance in an Era of Protectionism and Policy Volatility 
Via PRUnderground
Topics Economy Government World Trade
Enersys Stock Falls After-Hours On Tepid Q1 Forecast, Retail’s Upbeat Following Strong Finish To Fiscal 2025
The company projected its net sales in the range of $830 million to $870 million, below Wall Street’s estimated $906.9 million. 
Via Stocktwits
Topics Economy World Trade
CAE Stock Slips After RBC Capital Downgrade On Lack Of Catalysts: Retail’s Split
Last week, Jefferies said that the company’s Civil segment will face a "destocking" tied to early simulator shipments due to delayed aircraft and a sluggish U.S. hiring environment. 
Via Stocktwits
Topics Economy World Trade
ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved
RBC Capital noted that ResMed now has “a number of competitive threats on the horizon." 
Via Stocktwits
Topics Government
Discovery Senior Living to Participate in RBC Capital Markets Global Healthcare Conference
Bonita Springs, Florida--(Newsfile Corp. - May 20, 2025) - Discovery Senior Living (Discovery or the Company) and its affiliated companies,... 
Via Newsfile
Lowe's, Home Depot Results This Week Will Give Clear Picture Of Consumer Sentiment: Retail Upbeat
The two companies dominate the home improvement retail space, a category where consumer spending typically rises during periods of strong economic confidence. 
Via Stocktwits
Topics Bonds Credit Cards Economy
Why GitLab Stock Slumped by Nearly 5% on Monday
Via The Motley Fool
Topics World Trade
RBC Bearings Can Defy Macro Headwinds, Says Analyst, On Aerospace Strength, Tariff Resilience
Truist Securities analyst revised price forecast on RBC Bearings to $405, keeping Buy rating. Q4 EPS beat, sales missed. Q1 sales expected to be $424M-$434M. 
Via Benzinga
Topics Earnings
Why Fluence Energy Stock Was Flying High This Week
Via The Motley Fool
Topics Government World Trade
3 Mid-Cap Stocks Turning Heads in AI, Automation, & Cybersecurity
These mid-cap tech names may have the potential to foster robust innovation while enjoying a bit more stability than smaller firms in the sector. 
Via MarketBeat
Topics Artificial Intelligence
RBC Bearings (NYSE:RBC) Reports Sales Below Analyst Estimates In Q1 Earnings
Bearings manufacturer RBC Bearings (NYSE:RBC) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.8% year on year to $437.7 million. Next quarter’s revenue guidance of $429 million... 
Via StockStory
RBC Bearings Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
 
Via Benzinga
What's Next: RBC Bearings's Earnings Preview
 
Via Benzinga
RBC Bearings Earnings: What To Look For From RBC
Bearings manufacturer RBC Bearings (NYSE:RBC) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
Owens Corning’s Board Clears 12M Share Repurchase Ahead Of Investor Day — Stock Unmoved Pre-Market
The announcement follows a slew of price cuts from analysts after the company’s second-quarter outlook disappointed Wall Street. 
Via Stocktwits
Topics World Trade
UnitedHealth Regains Retail Confidence Amid After-Hours Rebound: Analysts React To CEO Exit, FY25 Guidance Suspension
At least two research firms said the stock may have bottomed following the “latest in a string of setbacks.” 
Via Stocktwits
1 Mid-Cap Stock to Target This Week and 2 to Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
CurrencyNewsBreaks – Aegis Capital Corp. Serves as Sole Book-Running Manager for Super League Enterprise (NASDAQ: SLE) $869,999 Public Offering
Via Investor Brand Network
Topics Retirement
Digital Ad Firm Trade Desk Rebounds With Better-Than-Expected Earnings
Trade Desk stock rose after the digital advertising firm rebounded with a better-than-expected Q1 after lowering expectations in early 2025. 
Via Investor's Business Daily
Wall Street Remains Overwhelmingly Bullish About This 9.2%-Yielding Dividend Stock Despite Economic Uncertainty and Volatility
Via The Motley Fool
Topics Economy Government World Trade
2 Popular AI Stock to Sell Before They Fall 64% and 67%, According to Certain Wall Street Analysts
Via The Motley Fool
Topics Artificial Intelligence Government
$1000 Invested In RBC Bearings 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Palantir Stock Plummets As Analysts Flag Valuation Risks Despite Q1 Revenue Beat
Analysts warn that while Palantir's execution is impressive, concerns remain that its stock trades at a valuation difficult to justify without further acceleration. 
Via Stocktwits
Topics Artificial Intelligence Earnings Government
Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug
The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands. 
Via Investor's Business Daily
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
Analysts Still Like Chevron, Cite Strong FCF & Balance Sheet As Key Amid OPEC And Recession Fears
B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also... 
Via Benzinga
Topics Economy
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Files Amended $700M Market Manipulation Complaint in Federal Court
Via Investor Brand Network
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.